8 days ago
LLY
AnalystsSeamus FernandezSeamus Fernandez's Stock Forecasts
AnalystsSeamus Fernandez
Analyst Ranking
Top 21%
#995 out of 4862 analysts
Average Return
+4.58%
Win Rate
51%25 out of 49
Risk vs Reward
Poor
Good
Seamus Fernandez's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Albireo Pharma IncALBO | +142.18% | $18.23 | $44.15 | 2022-09-07 - 2023-03-02 | Strong Buy |
Cymabay Therapeutics IncCBAY | +141.13% | $13.47 | $32.48 | 2023-08-10 - 2024-03-21 | Strong Buy |
Eli Lilly & CoLLY | +109.31% | $364.04 | $761.98 | 2023-04-10 - 2024-04-10 | Strong Buy |
Tesaro IncTSRO | +97.51% | $37.31 | $73.69 | 2018-09-24 - 2018-12-04 | Buy |
Apogee Therapeutics IncAPGE | +90.45% | $21.46 | $40.87 | 2023-08-07 - 2024-08-07 | Strong Buy |
Seamus Fernandez Analyst Color
Get additional color on Seamus Fernandez's coverage of popular stocks
5 months ago
APGE
8 months ago
LLY
a year ago
APGE
a year ago
APGE
2 years ago
MRK
2 years ago
LLY
3 years ago
MRK
Seamus Fernandez's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 7 | Strong Buy | $928.00 | +13.44% | Maintains | 8 days ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $44.00 | +475.92% | Reiterates | 12 days ago |
Vaxcyte IncPCVX | 4 | Strong Buy | $160.00 | +426.49% | Reiterates | a month ago |
Metsera IncMTSR | 1 | Strong Buy | $56.00 | +187.03% | Initiates Coverage On | 2 months ago |
Apogee Therapeutics IncAPGE | 5 | Strong Buy | $110.00 | +234.86% | Reiterates | 5 months ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $33.00 | +59.54% | Initiates Coverage On | 5 months ago |
Merck & Co IncMRK | 8 | Strong Buy | $130.00 | +66.99% | Maintains | 6 months ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $70.00 | +15.74% | Initiates Coverage On | 6 months ago |
Tenax Therapeutics IncTENX | 1 | Strong Buy | $16.00 | +211.28% | Initiates Coverage On | 6 months ago |
Icosavax IncICVX | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | a year ago |
Hillevax IncHLVX | 2 | Strong Buy | $34.00 | N/A | Maintains | a year ago |
Verve Therapeutics IncVERV | 1 | Strong Buy | $55.00 | N/A | Maintains | 2 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $36.00 | N/A | Reiterates | 2 years ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 2 years ago |
Structure Therapeutics IncGPCR | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 2 years ago |
Bristol Myers Squibb CoBMY | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Altimmune IncALT | 2 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Albireo Pharma IncALBO | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 3 years ago |
Invivyd IncIVVD | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Novartis AgNVS | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Dermira IncDERM2 | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Tesaro IncTSRO | 4 | Hold | $75.00 | N/A | Downgrades | 6 years ago |
Intra Cellular Therapies IncITCI | 3 | Buy | $27.00 | N/A | Initiates Coverage On | 6 years ago |
Allergan PLCAGN | 3 | Buy | $220.00 | N/A | Initiates Coverage On | 6 years ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $54.00 | N/A | Maintains | 7 years ago |
Celldex Therapeutics IncCLDX | 2 | Hold | $45.00 | N/A | Maintains | 7 years ago |
Astrazeneca PLCAZN | 2 | Hold | $38.00 | N/A | Maintains | 7 years ago |
Pfizer IncPFE | 1 | Hold | $38.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.